Dynamic Technology Lab Private Ltd Sells 45,342 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Dynamic Technology Lab Private Ltd lessened its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 68.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,850 shares of the company's stock after selling 45,342 shares during the quarter. Dynamic Technology Lab Private Ltd's holdings in Privia Health Group were worth $408,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Riverbridge Partners LLC raised its holdings in Privia Health Group by 19.7% during the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock worth $113,868,000 after buying an additional 958,418 shares during the last quarter. Loomis Sayles & Co. L P raised its holdings in shares of Privia Health Group by 55.0% in the 4th quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company's stock worth $27,727,000 after acquiring an additional 503,002 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Privia Health Group by 111.7% in the 4th quarter. JPMorgan Chase & Co. now owns 398,738 shares of the company's stock worth $7,795,000 after acquiring an additional 210,354 shares during the last quarter. Barclays PLC lifted its position in Privia Health Group by 240.3% in the 3rd quarter. Barclays PLC now owns 224,018 shares of the company's stock valued at $4,079,000 after acquiring an additional 158,188 shares in the last quarter. Finally, Cinctive Capital Management LP acquired a new position in Privia Health Group during the 4th quarter valued at about $2,723,000. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Privia Health Group Stock Up 0.2 %

Privia Health Group stock traded up $0.04 during trading on Tuesday, hitting $24.09. The stock had a trading volume of 66,872 shares, compared to its average volume of 784,360. The stock's 50 day moving average is $23.77 and its two-hundred day moving average is $21.56. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $26.04. The stock has a market cap of $2.92 billion, a price-to-earnings ratio of 240.82, a price-to-earnings-growth ratio of 3.47 and a beta of 0.88.

Insider Activity

In other news, CFO David Mountcastle sold 5,630 shares of the business's stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the sale, the chief financial officer now owns 179,676 shares of the company's stock, valued at $4,021,148.88. The trade was a 3.04 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 14.20% of the company's stock.

Analyst Ratings Changes

Several analysts have recently commented on PRVA shares. Needham & Company LLC reissued a "buy" rating and issued a $30.00 price objective on shares of Privia Health Group in a research note on Thursday, April 10th. Stephens restated an "overweight" rating and set a $26.00 price objective on shares of Privia Health Group in a research note on Thursday, January 2nd. JMP Securities set a $29.00 price objective on shares of Privia Health Group in a report on Friday, February 28th. Barclays increased their target price on shares of Privia Health Group from $21.00 to $23.00 and gave the company an "equal weight" rating in a report on Thursday, April 10th. Finally, Canaccord Genuity Group boosted their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a report on Friday, February 28th. One research analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $27.00.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.